Our research

The research contributes to the wellbeing of society and promotes local, national and international leadership through world-class research.

92 percent of our medical and health research is rated at or above world standard*, with particular strengths in:

  • Cardiovascular Medicine and Haematology
  • Ophthalmology and Optometry
  • Oncology and Carcinogenesis
  • Pharmacology and Pharmaceutical Sciences

Between 2012 and 2016, we were boosted by more than $38 million in funding from the National Health and Medical Research Council and Australian Research Council; our total research income for this period being more than $105m.

Our research is also driven through strong partnerships with industry and organisations, including the Flinders Medical Centre (FMC) Foundation, South Australia and Northern Territory health departments and collaborators around the world.

We’re a founding member of the South Australian Health and Medical Research Institute (SAHMRI) in partnership with the Government of South Australia, The University of Adelaide and University of South Australia.

Our multi-disciplinary research is conducted through a number of world-class research centres and at urban and rural clinical teaching hospitals in South Australia, NT and western Victoria.

*2015 Excellence in Research Australia (ERA) results

Research spotlight

Photo of Southgate staff

Southgate Institute for Health, Society and Equity

The Southgate Institute’s research informs initiatives and policy to promote population health and reduce health inequities and their underlying causes.

Key themes

  • Aboriginal and Torres Strait Islander health
  • Health equity and policy
  • Neighbourhoods, communities, housing and health
  • Primary health care and community services
  • Stigma and discrimination
  • Work and health
  • Centre of Research Excellence in the Social Determinants of Health Equity

Learn more ›

 

News

 

 

Publications

The information needs of adult cancer survivors across the cancer continuum: A scoping review.

Fletcher C, Flight I, Chapman J, Fennell K. Patient Education and Counseling, Vol100, Issue 3, March 2017.


Parthenolide Selectively Sensitizes Prostate Tumor Tissue to Radiotherapy while Protecting Healthy Tissues In Vivo.

Morel KL, Ormsby RJ, Bezak E, Sweeney CJ, Sykes PJ. Radiation Research 2017 May.


CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea

McEvoy RD, Antic NA, Heeley E, Neal B, Anderson CS et al for the SAVE Investigators and Coordinators; The New England Journal of Medicine, August 28 2016


A human neurodevelopmental model for Williams syndrome

Bardy C et al; Nature, 2016 Vol 536


The Impact of Comorbidity on Cancer and Its Treatment

Sarfati D, Koczwara B & Jackson C; Ca-A Cancer Journal For Clinicians, 2016 vol 66.